Persistent URL of this record https://hdl.handle.net/1887/3566368
In Collections
This item can be found in the following collections:
![Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial (vol 19, pg 295, 2018)](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial (vol 19, pg 295, 2018)
- All authors
- Boer, S.M. de; Powell, M.E.; Mileshkin, L.
- Date
- 2018-04-01
- Title of host publication
- The Lancet Oncology
- Volume
- 19
- Issue
- 4
- Pages
- E184 - E184